ROS1 IHC Lung Cancer Therapy Test | Lahalak Platform
Detects genetic defects in lung cancer cells to determine eligibility for smart targeted therapies, opening new horizons for more effective treatment with fewer side effects.
Scientific name: Immunohistochemistry (IHC) for ROS1
Immunohistochemical (IHC) or molecular assays are used to detect the ROS1 protein (c-ros oncogene 1), particularly in cases of ROS1 gene rearrangement. ROS1 gene rearrangement is an epigenetic (acquired) mutation that results in its fusion with other genes (such as CD74 and SLC34A2), producing a mutated protein that independently promotes cancer gr...
Included Services
- Detailed analysis to detect ROS1 gene rearrangement/expression in lung cancer tissue samples
- Consult with a pathologist and a thoracic oncologist to interpret the results.
- Personal support services.
Medical Service Information
Conditions & Notices
- The analysis does not require the patient to fast, as it is based on a preserved tumor tissue sample.
- The need for a sufficient tumor tissue sample (biopsy or excision) of suitable quality for molecular analysis.
- Ideally, the analysis should be performed as part of a comprehensive "genetic mutation package" for non-small cell lung cancer.